doxazosin has been researched along with isosorbide-5-mononitrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Çelik, O; Eryıldırım, B; Faydacı, G; Tarhan, F; Tosun, Ç | 1 |
1 trial(s) available for doxazosin and isosorbide-5-mononitrate
Article | Year |
---|---|
Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Doxazosin; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Lower Urinary Tract Symptoms; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Urinary Retention | 2014 |
2 other study(ies) available for doxazosin and isosorbide-5-mononitrate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |